SIGMAR1 and pulmonary arterial hypertension: In murine models, agonistic stimulation of Sigmar1 decreases cardiac fibroblast activation and fibrosis induced by pressure overload, heart failure, pulmonary arterial hypertension, and ventricular arrhythmias [62,63,64,65].